Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Hamm, B

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. [electronic resource] - Radiology Jun 1995 - 785-92 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

0033-8419

10.1148/radiology.195.3.7754011 doi


Adult
Biliary Tract--anatomy & histology
Contrast Media--adverse effects
Double-Blind Method
Gadolinium DTPA
Humans
Liver--anatomy & histology
Magnetic Resonance Imaging
Male
Organometallic Compounds--adverse effects
Pentetic Acid--adverse effects